NMRA vs WDAY · $283.5M cap vs P/E 135, rev $8.45B
Neumora Therapeutics, Inc. (NMRA) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported WDAY revenue for 2025-01-31 was $8.45B. Net income was $526.0M. Revenue was up 16.4% from 2024-01-31 to 2025-01-31. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
NMRA currently screens at market cap $283.5M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the NMRA and WDAY stock pages for the full models.
Not investment advice.